FASEB SRC on Matricellular Proteins in Inflammation and Tissue Remodeling
FASEB SRC 对炎症和组织重塑中基质细胞蛋白的影响
基本信息
- 批准号:9761800
- 负责人:
- 金额:$ 1.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:20 year oldAdhesionsAgeAgingAlzheimer&aposs DiseaseApoptosisArthritisAutoimmunityBasic ScienceBiological MarkersBiological ProcessBloom SyndromeCardiovascular DiseasesCardiovascular systemCell AdhesionCell Adhesion ProcessCell CommunicationCell Cycle ProgressionCell Surface ReceptorsCell physiologyCellsClinicalCockayne SyndromeCollaborationsCollagenComplexComplications of Diabetes MellitusCrohn&aposs diseaseCysteineDNA RepairDNA biosynthesisDataDefectDevelopmentDiabetes MellitusDiagnosisDisabled PersonsDisciplineDiseaseDyskeratosis CongenitaEnsureEnzymesExtracellular MatrixExtracellular Matrix ProteinsExtracellular ProteinExtracellular StructureEyeFamilyFanconi&aposs AnemiaFertilizationFibrosisFosteringGenderGene ExpressionGenomic InstabilityGlaucomaGoalsGrowth FactorHeart failureHuman PathologyHypertensionImmunityIndustryInfectionInflammationInternationalKidney FailureKnowledgeLeadLinkMacular degenerationMalignant NeoplasmsMechanicsMedicalMetabolismMinorityMolecularMolecular MachinesMorbidity - disease rateNeoplasm MetastasisOphthalmoplegiaParticipantPeptide HydrolasesPeripheral Nervous SystemPeripheral Vascular DiseasesPhenotypePhysiologicalPhysiological ProcessesPremature aging syndromeProcessProteinsRNA SplicingRNA TransportReactive Oxygen SpeciesReceptor CellRecording of previous eventsRegulationReportingReproductive systemResearchResearch PersonnelReview LiteratureRoleRothmund-Thomson syndromeScienceScientistSignal TransductionStressStrokeStructureSyndromeSystemTenascinTherapeutic AgentsTherapeutic InterventionThrombospondin 1ThrombospondinsTissuesTranslational ResearchTrichothiodystrophyUnderrepresented GroupsUniversitiesVascular remodelingWashingtonWerner SyndromeWisconsinWomanWorkXeroderma Pigmentosumangiogenesiscareer developmentcell growth regulationchronic woundclinical applicationdesignethnic minority populationfamily structurefibulinhelicasehuman diseaseinnovationinterestmeetingsmigrationmortalityneurogenesisnovelosteopontinpainful neuropathyperiostinpostersprogramsprotein complexracial and ethnicrepairedresponseskeletal dysplasiasupportive environmentsymposiumtargeted treatmenttherapeutic proteintherapeutic targetthrombospondin 4
项目摘要
Abstract
The FASEB Scientific Research Conference “Matricellular Proteins in Inflammation and Tissue Remodeling”
continues a more than 20-year history of conferences dedicated to matricellular proteins, a family of secreted
modulatory adhesion proteins regulating interactions between cells and ECM. Matricellular proteins include a
structurally diverse group of extracellular proteins, which regulate a wide array of key cellular processes,
including cell adhesion, migration, survival, proliferation, extracellular matrix organization, growth factor and
protease regulation, and differentiation. Of importance are emerging data showing key roles for matricellular
proteins in diseases through their roles in regulating tissue remodeling, angiogenesis, fibrosis, inflammation,
immunity, metabolism, and development. Matricellular proteins are therapeutic targets for multiple diseases,
including cardiovascular disease, cancer and metastasis, autoimmunity, neurogenesis and neuropathic pain,
ocular diseases including inflammation, glaucoma, and macular degeneration, diabetes and diabetic
complications, skeletal dysplasia, and arthritis. The field has evolved from elucidating structure function
activities of these complex proteins to identifying roles in diseases and the development of matricellular-
targeted therapeutic interventions. The 2019 conference will be the 8th conference dedicated to matricellular
proteins. The FASEB SRC “Matricellular Proteins” is unique in that it is the only meeting focusing on the group
of matricellular proteins that can bring together researchers, clinicians, and industry representatives from
different fields and disciplines, who focus on specific matricellular proteins (thrombospondins, CCNs, SPARC,
tenascins, etc.) in various contexts. The aims of the conference are:
Aim 1. To bring together researchers with active interests in the structures, functions, and clinical applications
of matricellular proteins and to create a forum for free exchange of ideas and new unpublished information
among international researchers to ensure continued progress and innovation in the field.
Aim 2. To promote translation of research findings into novel clinical therapies.
Aim 3. To foster the development of young scientists through dissemination of their work and through
meaningful exchanges with established scientists.
The conference is designed to assure an appropriate representation of women and minority participants, as
well as participation of young investigators and trainees. In addition to the scientific sessions, poster sessions,
a career development session, and a “Meet the expert” dinner are planned to facilitate the interactions of
trainees and young investigators with established leaders of the field and to provide a friendly and supportive
environment for the exchange of scientific ideas.
摘要
FASEB科学研究会议“炎症和组织重塑中的基质细胞蛋白质”
延续了20多年的会议历史,致力于matricellular蛋白,一个家庭的分泌
调节细胞和ECM之间相互作用的调节粘附蛋白。基质细胞蛋白包括
结构多样化的细胞外蛋白质组,调节多种关键细胞过程,
包括细胞粘附、迁移、存活、增殖、细胞外基质组织、生长因子和
蛋白酶调节和分化。重要的是,新出现的数据显示,
蛋白质通过它们在调节组织重塑、血管生成、纤维化、炎症
免疫、新陈代谢和发育。基质细胞蛋白是多种疾病的治疗靶点,
包括心血管疾病、癌症和转移、自身免疫、神经发生和神经性疼痛,
眼部疾病,包括炎症、青光眼和黄斑变性、糖尿病和糖尿病
并发症、骨骼发育不良和关节炎。该领域已经从阐明结构功能
这些复合蛋白的活性,以确定在疾病和基质细胞的发展中的作用,
有针对性的治疗干预。2019年会议将是第8届会议致力于matricellular
proteins. FASEB SRC“基质细胞蛋白质”是独一无二的,因为它是唯一的会议集中在该组
的研究人员,临床医生和行业代表,
不同的领域和学科,谁专注于特定的基质细胞蛋白质(血小板反应蛋白,CCN,β,
生腱蛋白等)in various不同context上下文.会议的目的是:
目标1.汇集对结构,功能和临床应用感兴趣的研究人员
并创建一个论坛,供自由交流思想和新的未发表的信息
国际研究人员之间的合作,以确保该领域的持续进步和创新。
目标2.促进将研究成果转化为新的临床疗法。
目标3.通过传播青年科学家的工作成果,
与知名科学家进行有意义的交流。
会议旨在确保妇女和少数民族与会者的适当代表性,
以及青年调查员和受训人员的参与。除了科学会议,海报会议,
计划举办职业发展会议和“会见专家”晚宴,以促进
学员和年轻的调查人员与该领域的既定领导人,并提供友好和支持
科学思想交流的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OLGA I STENINA其他文献
OLGA I STENINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OLGA I STENINA', 18)}}的其他基金
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
糖尿病相关癌症生长的组织特异性调节
- 批准号:
9070628 - 财政年份:2014
- 资助金额:
$ 1.9万 - 项目类别:
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
糖尿病相关癌症生长的组织特异性调节
- 批准号:
8882346 - 财政年份:2014
- 资助金额:
$ 1.9万 - 项目类别:
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
糖尿病相关癌症生长的组织特异性调节
- 批准号:
8760085 - 财政年份:2014
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7860426 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7437338 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7140806 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7632244 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7273563 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Regulation of thrombospondin-1 expression by glucose
葡萄糖对血小板反应蛋白-1 表达的调节
- 批准号:
7777469 - 财政年份:2006
- 资助金额:
$ 1.9万 - 项目类别:
Proatherogenic effect of thrombospondins in diabetes
血小板反应蛋白在糖尿病中的促动脉粥样硬化作用
- 批准号:
6747968 - 财政年份:2002
- 资助金额:
$ 1.9万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 1.9万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 1.9万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 1.9万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 1.9万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 1.9万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 1.9万 - 项目类别:














{{item.name}}会员




